NewslettersCancer Stem Cell NewsMammary Cell NewsDownregulation of TAB182 Promotes Cancer Stem-Like Cell Properties and Therapeutic Resistance in Triple-Negative Breast Cancer CellsBy Bob - November 15, 20230138The authors revealed a novel function of TAB182 as a potential negative regulator of cancer stem-like properties and drug sensitivity in triple-negative breast cancer cells.[BMC Cancer]Full Article